All News

NKx

Scribe and Sanofi Expand Collaboration Further to Advance Genetic Treatments
18 July 2023
Scribe and Sanofi Expand Collaboration Further to Advance Genetic Treatments
Scribe and Sanofi Expand Collaboration
Imperial’s NK:IO Awarded $2.09M Grant for the Development of NK Cell Therapy
14 July 2023
Imperial’s NK:IO Awarded $2.09M Grant for the Development of NK Cell Therapy
Imperial’s NK:IO Awarded $2.09M Grant
BioCentriq and panCELLa in Agreement to Study Stem Cell-derived Natural Killer Cell Expansion Technology
9 May 2023
BioCentriq and panCELLa in Agreement to Study Stem Cell-derived Natural Killer Cell Expansion Technology
BioCentriq and panCELLa Collab in
FDA RMAT Designation Granted to Fate Therapeutics for FT516 Treatment of Relapsed/Refractory DLBCL
16 December 2021
FDA RMAT Designation Granted to Fate Therapeutics for FT516 Treatment of Relapsed/Refractory DLBCL
News
POPULAR NEWS ITEMS
Image
4 December 2023

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image
6 December 2023

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image
5 December 2023

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome

Strategic Manufacturing Partnership Announced Between Gates Biomanufacturing Facility and Nkarta
6 October 2021
Strategic Manufacturing Partnership Announced Between Gates Biomanufacturing Facility and Nkarta
News
Next-Generation CAR-T, Car-M and NK/NKT Platform Launched, Focussed on Curing Difficult-To-Treat Cancers
16 June 2021
Next-Generation CAR-T, Car-M and NK/NKT Platform Launched, Focussed on Curing Difficult-To-Treat Cancers
Inceptor Bio has announced the
Research Collaboration Seeks to Optimise Dual-Targeted NK Cell Therapy Against Acute Myeloid Leukaemia
26 May 2021
Research Collaboration Seeks to Optimise Dual-Targeted NK Cell Therapy Against Acute Myeloid Leukaemia
A new research agreement, funded
Enabling Next Generation Cell Therapies with GMP-Grade Human iPSCs
3 March 2021
Enabling Next Generation Cell Therapies with GMP-Grade Human iPSCs
Are induced pluripotent stem cells
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry

Image

Oxford Biomedica Acquires ABL Europe from Institut Mérieux

Image

Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome